A rolling review has been launched by the European Medicines Agency's Committee for Medicinal Products for Human Use for Russia’s Sputnik V COVID-19 vaccine. Developed by the Gamaleya National Centre of Epidemiology and Microbiology in Russia, the application in Europe for Sputnik V was filed by R-Pharm Germany.
EMA begins rolling review for Russian COVID-19 vaccine
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.